trial

Lifestyle Modification for Weight Loss in Schizophrenia

NCTId NCT00990925
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 149 (actual)
Sponsored by Yale University
Primary completion 2012-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
149 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2009-10
Primary completion
2012-02
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Nutritional Lifestyle Modification Group

Sponsors

Yale UniversityLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Cenk Tek, M.D.Principal Investigator

Sites

1 total
New Haven, United States

Facts & assertions

4 sourced
Enrollment
149
Phase
NA
Primary Completion Date
2012-02
Status
COMPLETED
relationships
The graph out of here
drug
Nutritional Lifestyle Modification Group
drug
lead_sponsor
Yale University
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Obesity
indication
Schizoaffective Disorder
indication
Weight Loss
indication
investigator
Cenk Tek, M.D.
person